Chemoinformaics analysis of (2E,4E)-2,4-Decadienoic acid
Molecular Weight | 168.236 | nRot | 6 |
Heavy Atom Molecular Weight | 152.108 | nRig | 3 |
Exact Molecular Weight | 168.115 | nRing | 0 |
Solubility: LogS | -2.453 | nHRing | 0 |
Solubility: LogP | 2.785 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.9727 |
nHD | 1 | BPOL | 16.9193 |
QED | 0.489 |
Synth | 2.715 |
Natural Product Likeliness | 2.045 |
NR-PPAR-gamma | 0.11 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.008 |
CACO-2 | -4.591 |
MDCK | 0.0000304 |
BBB | 0.798 |
PPB | 0.926409 |
VDSS | 0.229 |
FU | 0.0892312 |
CYP1A2-inh | 0.035 |
CYP1A2-sub | 0.33 |
CYP2c19-inh | 0.022 |
CYP2c19-sub | 0.223 |
CYP2c9-inh | 0.022 |
CYP2c9-sub | 0.969 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.413 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.065 |
CL | 3.07 |
T12 | 0.833 |
hERG | 0.032 |
Ames | 0.03 |
ROA | 0.86 |
SkinSen | 0.957 |
Carcinogencity | 0.667 |
EI | 0.983 |
Respiratory | 0.94 |
NR-Aromatase | 0.043 |
Antiviral | No |
Prediction | 0.941962 |